Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Fibroblast growth factor receptor signaling in cardiomyocytes is protective in the acute phase following ischemia-reperfusion injury

Frontiers in Cardiovascular Medicine(2022)10.3389/fcvm.2022.1011167Source: DataRank Database

Fibroblast growth factor receptor signaling in cardiomyocytes is protective in the acute phase following ischemia-reperfusion injury is a research paper published in Frontiers in Cardiovascular Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.71)OA: goldTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Stacey L. House ORCID,Carla J. Weinheimer ORCID,Attila Kovács ORCID,David M. Ornitz ORCID,Dzmitry Matsiukevich ORCID

Live enrichment

PubMed:36211556 PMC:PMC9539275 OpenAlex:https://openalex.org/W4296998452

NIH HHS

Grant: S10 OD028597

National Institutes of Health

Grant: 5R01HL105732-03

FIBROBLAST GROWTH FACTOR SIGNALING IN HEART INJURY AND REPAIR

FWCI

0.71

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fcvm.2022.1011167

publisherhttps://doi.org/10.3389/fcvm.2022.1011167

publisherhttps://www.frontiersin.org/articles/10.3389/fcvm.2022.1011167/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36211556

repositoryhttps://digitalcommons.wustl.edu/oa_4/1816

Fields of Study

Fibroblast Growth Factor ResearchNitric Oxide and Endothelin EffectsCardiovascular Function and Risk Factors0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

CardioprotectionMedicineIschemiaReperfusion injuryFibroblast growth factorMyocyteFibroblast growth factor receptorCardiac myocyteFibroblast growth factor receptor 1Cardiac function curveInternal medicineCardiologyEndocrinologyReceptorHeart failureCardiomyocyteIschemia-reperfusion injuryFgfr2Fgfr1ICTS (Institute of Clinical and Translational Sciences)610Cardiovascular MedicineRC666-701616Emergency MedicineMedicine and Health SciencesDiseases of the circulatory (Cardiovascular) system

Sustainable Development Goals

SDG 0: Good health and well-being